1300
M. Gravel et al.
FEATURE ARTICLE
(1R,2R)-2-Methyl-1-phenylbut-3-en-1-ol (24)39
Colorless oil (29 mg, 60%).
[a]25D +92.0 [c = 1.62, CHCl3, lit.13 –73.4 (66% ee) for the opposite
enantiomer].
1H NMR (500 MHz, CDCl3): d = 7.35–7.24 (m, 5 H), 5.80 (ddd, 1
H, J = 17.2, 10.5, 8.2 Hz), 5.20–5.15 (m, 2 H), 4.35 (d, 1 H, J = 7.8
Hz), 2.49–2.45 (m, 1 H), 2.15 (br s, 1 H), 0.86 (d, 3 H, J = 6.8 Hz).
[a]25D +16.55 (c = 2.00, CHCl3).
IR (CH2Cl2 cast): 3363, 2959, 2932, 1457, 1378, 1019 cm–1.
1H NMR (500 MHz, CDCl3): d = 5.82 (ddd, 1 H, J = 17.7, 10.4, 7.6
Hz), 5.17–5.12 (m, 2 H), 4.19 (ddd, 1 H, J = 6.2, 3.8, 1.9 Hz), 2.44–
2.40 (m, 1 H), 2.21 (ddd, 2 H, J = 9.0, 7.1, 1.9 Hz), 1.82 (br s, 1 H),
1.54–1.48 (m, 2 H), 1.40–1.29 (m, 4 H), 1.12 (d, 3 H, J = 7.1 Hz),
0.90 (t, 3 H, J = 7.1 Hz).
13C NMR (125 MHz, CDCl3): d = 142.4, 140.6, 128.2, 127.6, 126.8,
116.8, 77.9, 46.3, 16.5.
13C NMR (125 MHz, CDCl3): d = 139.6, 116.4, 86.6, 79.5, 66.4,
44.7, 31.0, 28.3, 22.1, 18.6, 15.2, 13.9.
HPLC: Chiralcel OD-RH, 30% i-PrOH–H2O, 0.45 mL/min, UV de-
tection at 210 nm, major peak at 106.8 min, minor peak at 118 min,
97% ee.
19F NMR (376 MHz, CDCl3): d = –71.88 (major), –72.14 (minor);
97% ee on the Mosher ester derivative.
HRMS (ES): m/z calcd for C12H20ONa: 203.14064; found:
203.14084.
(3S,4R)-4-Methyl-1-phenylhex-5-en-3-ol (25)13
Colorless oil (41 mg, 71%).
[a]25D –14.7 [c = 1.42, CHCl3, lit.13 +13.8 (86% ee) for the opposite
enantiomer].
1H NMR (500 MHz, CDCl3): d = 7.28–7.15 (m, 5 H), 5.73 (ddd, 1
H, J = 16.7, 10.8, 8.2 Hz), 5.12–5.08 (m, 2 H), 3.40 (ddd, 1 H,
J = 9.1, 6.0, 3.1 Hz), 2.85–2.63 (m, 2 H), 2.23–2.19 (m, 1 H), 1.86–
1.65 (m, 2 H), 1.56 (br s, 1 H), 1.02 (d, 3 H, J = 6.9 Hz).
13C NMR (125 MHz, CDCl3): d = 142.2, 140.1, 128.4, 128.3, 125.7,
116.4, 74.0, 44.4, 36.2, 32.2, 16.3.
Synthesis of syn-Homoallylic Alcohols 29–33; General Proce-
dure
Scandium trifluoromethanesulfonate (16 mg, 0.03 mmol) and
CH2Cl2 (0.3 mL) were introduced in a 10-mL round-bottom flask,
and the mixture was cooled to –78 °C. The aldehyde (0.50 mmol)
was added, followed by a solution of boronate 8a (102 mg, 0.33
mmol) in CH2Cl2 (0.3 mL) dropwise over 5 min. The resulting mix-
ture was stirred at –78 °C for 24 h, then DIBAL-H (1.0 M in tolu-
ene, 1.00 mL, 1.00 mmol) was added. The mixture was stirred at
–78 °C for 30 min, then 1 N HCl (5 mL) was carefully added and
the flask was allowed to warm up to ambient temperature. The re-
sulting layers were separated, then the aqueous layer was extracted
with EtOAc (3 × 5 mL). The combined organic layers were dried
over MgSO4, filtered and concentrated. Flash chromatography (5%
EtOAc–hexanes) afforded the pure homoallylic alcohol.
HPLC: Chiralcel AD-RH, 40% i-PrOH–H2O, 0.33 mL/min, UV de-
tection at 210 nm, major peak at 64.8 min, minor peak at 73.3 min,
96% ee.
(3S,4R)-1-{[t-Butyl(diphenyl)silyl]oxy}-4-methylhex-5-en-3-ol
(26)40
(1R,2S)-2-Methyl-1-phenylbut-3-en-1-ol (29)42
Colorless oil (28.5 mg, 53%).
Colorless oil (70 mg, 63%).
[a]25D +4.4 [c = 1.46, CHCl3, lit.40 +3.0 (mixture of diastereomers)].
1H NMR (500 MHz, CDCl3): d = 7.72–7.67 (m, 4 H), 7.44–7.35 (m,
6 H), 5.90 (ddd, 1 H, J = 16.7, 11.1, 8.0 Hz), 5.08–5.04 (m, 2 H),
3.90–3.82, (m, 2 H), 3,77–3.74 (m, 1 H), 2.97 (br s, 1 H), 2.27–2.23
(m, 1 H), 1.71–1.63 (m, 2 H), 1.06 (d, 3 H, J = 6.9 Hz), 1.05 (s, 9 H).
TLC (10% EtOAc–toluene, PMA): 0.23.
[a]25 +12.0 (c = 1.47, CHCl3, lit.13,42 –15.0 for the opposite enan-
D
tiomer, +15.2).
1H NMR (300 MHz, CDCl3): d = 7.38–7.24 (m, 5 H), 5.83–5.70 (m,
1 H), 5.10–5.07 (m, 1 H), 5.05–5.02 (m, 1 H), 4.63 (d, 1 H, J = 5.5
Hz), 2.66–2.53 (m, 1 H), 1.91 (br s, 1 H), 1.02 (d, 3 H, J = 6.8 Hz).
13C NMR (125 MHz, CDCl3): d = 140.6, 135.6, 133.2, 129.8, 127.7,
115.2, 74.5, 63.3, 43.9, 35.6, 26.8, 19.0, 15.8.
13C NMR (125 MHz, CDCl3): d = 142.5, 140.3, 128.0, 127.3, 126.5,
HPLC: Chiralcel AD-RH, 55% i-PrOH–H2O, 0.31 mL/min, UV de-
tection at 210 nm, minor peak at 27.7 min, major peak at 31.9 min,
94% ee.
115.5, 77.3, 44.6, 14.0.
HPLC: Chiralcel OD-RH, 35% i-PrOH–H2O, 0.40 mL/min, UV de-
tection at 210 nm, major peak at 61.5 min, minor peak at 68.7 min,
59% ee.
(2R,3R)-1-{[t-Butyl(dimethyl)silyl]oxy}-3-methylpent-4-en-2-ol
(27)41
(3S,4S)-4-Methyl-1-phenylhex-5-en-3-ol (30)34
Colorless oil (32 mg, 52%).
Colorless oil (44 mg, 63%).
[a]25D +2.8 (c = 0.73, CHCl3).
1H NMR (500 MHz, CDCl3): d = 5.84 (m, 1 H), 5.06–5.02 (m, 2 H),
3.63–3.60 (m, 1 H), 3.50–3.47 (m, 2 H), 2.35 (d, 1 H, J = 2 Hz), 2.30
(apparent sextet, 1 H, J = 7.0 Hz), 1.02 (d, 3 H, J = 6.8 Hz), 0.88 (s,
9 H), 0.05 (s, 6 H).
13C NMR (125 MHz, CDCl3): d = 140.3, 115.0, 74.8, 65.2, 41.4,
25.8, 18.2, 16.1, –5.4.
TLC (10% EtOAc–toluene, PMA): 0.35.
[a]25D –32.5 (c = 0.80, CHCl3).
1H NMR (500 MHz, CDCl3): d = 7.28–7.24 (m, 2 H), 7.20–7.14 (m,
3 H), 5.79–5.72 (m, 1 H), 5.10–5.07 (m, 1 H), 5.06–5.05 (m, 1 H),
3.50 (ddd, 1 H, J = 8.8, 5.0, 3.1 Hz), 2.84 (ddd, 1 H, J = 13.9, 10.2,
5.3 Hz), 2.63 (ddd, 1 H, J = 13.7, 9.8, 6.7 Hz), 2.32–2.24 (m, 1 H),
1.84–1.77 (m, 1 H), 1.72–1.63 (m, 1 H), 1.41 (br s, 1 H), 1.01 (d, 3
H, J = 6.9 Hz).
HRMS (EI): m/z calcd for C8H17O2Si (M – t-Bu): 173.09978; found:
173.09970.
13C NMR (125 MHz, CDCl3): d = 142.2, 140.7, 128.4, 128.4, 125.8,
HPLC (performed on the carbamate derivative from reaction with
phenylisocyanate): Chiralcel OD, 2% i-PrOH–hexane, 0.30 mL/
min, UV detection at 210 nm, major peak at 26.2 min, minor peak
at 24.8 min, 96% ee.
115.5, 74.1, 43.6, 35.8, 32.4, 14.2.
HPLC: Chiralcel AD-RH, 40% i-PrOH–H2O, 0.33 mL/min, UV de-
tection at 210 nm, major peak at 53.9 min, minor peak at 60.0 min,
96% ee.
(3R,4R)-3-Methylundec-1-en-5-yn-4-ol (28)
Colorless oil (48 mg, 78%).
Synthesis 2004, No. 8, 1290–1302 © Thieme Stuttgart · New York